According to the FDA’s website, the following state of the propofol injection shortage is as follows:
- Teva Pharmaceuticals has recently released some propofol 20-mL, 50-mL and 100-mL vials and expects additional quantities over the coming months.
- Hospira Pharmaceuticals has released some propofol 20-mL, 50-mL and 100-mL and expects additional quantities in the coming months.
- APP has increased production in response to the increased demand as well as received approval to release imported Fresenius Propoven 1%.
The FDA’s new website on the propofol shortage is available here.
Read the ASA’s release on the propofol shortage.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
